Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

614
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
614
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

565
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
565
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

544
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
544
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

583
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
583
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

513
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
513
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

850
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
850

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond Medication: Integrative and Nutrition Therapies for Disorders of Gut-Brain Interaction.

Gastroenterology & hepatology·2026
Same author

A Primer for Discussing Complementary and Integrative Medicine in Gastroenterology Settings.

Neurogastroenterology and motility·2026
Same author

Artificial Intelligence for Gastroenterology Practice: A Modified Delphi Consensus.

The American journal of gastroenterology·2026
Same author

The Effectiveness of Plecanatide for Treating Constipation and Bloating in Patients Aged 18 to 40 Years With Irritable Bowel Syndrome: Utilization of a New Composite Trisymptom Endpoint.

Journal of gastroenterology and hepatology·2025
Same author

Tenapanor Improves Abdominal Symptoms Irrespective of Changes in Complete Spontaneous Bowel Movement Frequency in Adults with Irritable Bowel Syndrome with Constipation.

Digestive diseases (Basel, Switzerland)·2024
Same author

Emotional Intelligence: An Impactful Yet Often Overlooked Skill That Can Enhance Physician Well-being and Professional Satisfaction.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2024

Related Experiment Video

Updated: Dec 28, 2025

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
04:04

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation

Published on: July 5, 2024

875

Complementary and Alternative Medicine for Functional Gastrointestinal Disorders.

Jill K Deutsch1, Joshua Levitt2, David J Hass1,3

  • 1Yale University School of Medicine, Yale New Haven Hospital, Section of Digestive Diseases - Department of Internal Medicine, New Haven, Connecticut, USA.

The American Journal of Gastroenterology
|February 22, 2020
PubMed
Summary

Functional gastrointestinal (GI) disorders significantly impact patient quality of life. This review explores complementary and alternative therapies for conditions like functional dyspepsia and irritable bowel syndrome.

More Related Videos

Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes
06:01

Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes

Published on: July 26, 2024

969
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

1.1K

Related Experiment Videos

Last Updated: Dec 28, 2025

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
04:04

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation

Published on: July 5, 2024

875
Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes
06:01

Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes

Published on: July 26, 2024

969
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

1.1K

Area of Science:

  • Gastroenterology
  • Digestive Health
  • Patient Quality of Life

Background:

  • Functional gastrointestinal (GI) disorders are prevalent, affecting up to 40% of patients seen by gastroenterologists.
  • These complex disorders significantly impact patients' quality of life.
  • Many patients seek complementary and alternative therapies (CAT) for symptom management.

Purpose of the Study:

  • To provide gastroenterologists with information and treatment algorithms for common CAT.
  • To enhance the understanding and application of CAT for functional GI disorders.
  • To support clinicians in managing patients with functional dyspepsia, nausea/vomiting, and irritable bowel syndrome.

Main Methods:

  • This is a narrative review.
  • Information on common complementary and alternative therapies was compiled.
  • Treatment algorithms were developed for clinical guidance.

Main Results:

  • Functional GI disorders represent a substantial patient population in gastroenterology.
  • Complementary and alternative therapies are frequently utilized by patients with functional GI disorders.
  • Positive therapeutic outcomes are often reported by patients using these therapies.

Conclusions:

  • Gastroenterologists require a strong knowledge base in managing functional GI disorders.
  • Complementary and alternative therapies offer viable options for patients with functional GI disorders.
  • This review equips physicians with tools to integrate common CAT into patient care.